Active Ingredient: CROFELEMER
Proprietary Name: MYTESI
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: 125MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N202292
Product Number: 001
Approval Date: Dec 31, 2012
Applicant Holder Full Name: NAPO PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
